Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.